Pierre‐François Plouin

17.5k total citations · 3 hit papers
140 papers, 9.9k citations indexed

About

Pierre‐François Plouin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pierre‐François Plouin has authored 140 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Surgery, 71 papers in Endocrinology, Diabetes and Metabolism and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pierre‐François Plouin's work include Hormonal Regulation and Hypertension (56 papers), Adrenal and Paraganglionic Tumors (55 papers) and Renal and Vascular Pathologies (32 papers). Pierre‐François Plouin is often cited by papers focused on Hormonal Regulation and Hypertension (56 papers), Adrenal and Paraganglionic Tumors (55 papers) and Renal and Vascular Pathologies (32 papers). Pierre‐François Plouin collaborates with scholars based in France, United States and Belgium. Pierre‐François Plouin's co-authors include Laurence Amar, Xavier Jeunemaı̂tre, Anne‐Paule Gimenez‐Roqueplo, Gilles Châtellier, Jean‐Jacques Mourad, Olivier Steichen, Michel E. Safar, Xavier Girerd, Jacques Blacher and Paul Milliez and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Pierre‐François Plouin

138 papers receiving 9.6k citations

Hit Papers

Evidence for an increased rate of cardiovascular events i... 2005 2026 2012 2019 2005 2013 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
    2005 1.1k citations Pierre‐François Plouin, Jean‐Jacques Mourad et al. profile →
  2. Cardiovascular Complications Associated With Primary Aldosteronism
    2013 340 citations Sébastien Savard, Laurence Amar et al. profile →
  3. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
    2015 329 citations Michel Azizi, Philippe Gosse et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre‐François Plouin France 47 6.2k 5.7k 2.9k 1.9k 1.6k 140 9.9k
Anne‐Paule Gimenez‐Roqueplo France 55 8.9k 1.4× 7.5k 1.3× 7.1k 2.4× 1.2k 0.6× 987 0.6× 166 13.1k
Marcus Quinkler Germany 54 4.0k 0.6× 6.7k 1.2× 1.6k 0.5× 544 0.3× 597 0.4× 250 9.3k
Sergio Fazio United States 44 4.6k 0.7× 2.3k 0.4× 1.2k 0.4× 1.9k 1.0× 372 0.2× 143 8.0k
Michael J. Koren United States 36 6.4k 1.0× 2.1k 0.4× 1.0k 0.4× 3.8k 2.0× 534 0.3× 102 10.2k
Emmanuel L. Bravo United States 40 3.3k 0.5× 3.0k 0.5× 958 0.3× 1.3k 0.7× 497 0.3× 116 5.2k
Odette Poirier France 50 1.6k 0.3× 3.4k 0.6× 770 0.3× 4.4k 2.3× 783 0.5× 115 9.2k
Antonio Fernández‐Ortíz Spain 52 5.0k 0.8× 1.2k 0.2× 496 0.2× 7.6k 3.9× 1.5k 0.9× 360 11.1k
Anand Vaidya United States 44 2.9k 0.5× 3.8k 0.7× 309 0.1× 1.3k 0.7× 515 0.3× 178 6.2k
Tomohiro Sakamoto Japan 44 1.7k 0.3× 1.3k 0.2× 439 0.1× 3.4k 1.8× 790 0.5× 213 6.6k
Gilbert H. Daniels United States 42 3.2k 0.5× 9.8k 1.7× 282 0.1× 1.4k 0.7× 480 0.3× 102 12.3k

Countries citing papers authored by Pierre‐François Plouin

Since Specialization
Citations

This map shows the geographic impact of Pierre‐François Plouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐François Plouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐François Plouin more than expected).

Fields of papers citing papers by Pierre‐François Plouin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐François Plouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐François Plouin. The network helps show where Pierre‐François Plouin may publish in the future.

Co-authorship network of co-authors of Pierre‐François Plouin

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐François Plouin. A scholar is included among the top collaborators of Pierre‐François Plouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐François Plouin. Pierre‐François Plouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toubiana, Laurent, Alessandra Giavarini, Jérémie Riquier, et al.. (2015). A "pivot" Model to set up Large Scale Rare Diseases Information Systems: Application to the Fibromuscular Dysplasia Registry.. PubMed. 210. 887–91. 2 indexed citations
2.
Jaulent, Marie‐Christine, Sébastien Savard, Alessandra Giavarini, et al.. (2015). Building a Semantic Interoperability Framework for Care and Research in Fibromuscular Dysplasia. Studies in health technology and informatics. 216. 217–21. 3 indexed citations
3.
Azizi, Michel, Ludivine Perdrix, Guillaume Bobrie, et al.. (2014). Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension. Journal of Hypertension. 32(10). 2038–2044. 13 indexed citations
4.
Berthon, Annabel, Coralie Drelon, Bruno Ragazzon, et al.. (2013). WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Human Molecular Genetics. 23(4). 889–905. 148 indexed citations
5.
Postel‐Vinay, Nicolas, Guillaume Bobrie, Olivier Steichen, et al.. (2013). HY-Quest, standardized patient questionnaire to be completed at home before a first visit for hypertension. Journal of Hypertension. 32(3). 693–698. 3 indexed citations
6.
Loriot, Céline, Nelly Burnichon, Laure Vescovo, et al.. (2012). Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations. The Journal of Clinical Endocrinology & Metabolism. 97(6). E954–E962. 83 indexed citations
7.
Bobrie, Guillaume, Michael Frank, Michel Azizi, et al.. (2012). Sequential nephron blockade versus sequential renin–angiotensin system blockade in resistant hypertension. Journal of Hypertension. 30(8). 1656–1664. 74 indexed citations
8.
Burnichon, Nelly, Laure Vescovo, Laurence Amar, et al.. (2011). Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Human Molecular Genetics. 20(20). 3974–3985. 220 indexed citations
9.
Burnichon, Nelly, Charlotte Lussey‐Lepoutre, Julien Laffaire, et al.. (2010). A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma. European Journal of Endocrinology. 164(1). 141–145. 32 indexed citations
10.
Plouin, Pierre‐François, et al.. (2010). Phaeochromocytomas and functional paragangliomas: Clinical management. Best Practice & Research Clinical Endocrinology & Metabolism. 24(6). 933–941. 20 indexed citations
11.
Amar, Laurence, Pierre‐François Plouin, & Olivier Steichen. (2010). Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet Journal of Rare Diseases. 5(1). 9–9. 58 indexed citations
12.
Favier, Judith, Jean-Jacques Brière, Nelly Burnichon, et al.. (2009). The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas. PLoS ONE. 4(9). e7094–e7094. 187 indexed citations
13.
Plouin, Pierre‐François, Anne‐Paule Gimenez‐Roqueplo, & Xavier Bertagna. (2008). Le réseau national COMETE sur les tumeurs de la surrénale. Bulletin de l Académie Nationale de Médecine. 192(1). 73–85. 6 indexed citations
14.
Bobrie, Guillaume, et al.. (2006). Blood pressure and renal outcomes in patients with kidney infarction and hypertension. Journal of Hypertension. 24(8). 1649–1654. 67 indexed citations
15.
Lamarre-Cliché, Maxime, Anne‐Paule Gimenez‐Roqueplo, Eliane M. Billaud, et al.. (2002). Effects of slow‐release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma. Clinical Endocrinology. 57(5). 629–634. 37 indexed citations
16.
Rossignol, Patrick, Gilles Châtellier, Michel Azizi, & Pierre‐François Plouin. (2002). Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size. Journal of Hypertension. 20(1). 139–144. 12 indexed citations
17.
Corvol, Pierre & Pierre‐François Plouin. (2002). [Angiotensin II receptor blockers: current status and future prospects].. PubMed. 62 Spec No 1. 53–64. 12 indexed citations
18.
Plouin, Pierre‐François, et al.. (2001). Phéochromocytomes : progrès dans le diagnostic, la prise en charge et la physiopathologie. 3(4). 25–29. 1 indexed citations
19.
Gimenez‐Roqueplo, Anne‐Paule, Judith Favier, Pierre Rustin, et al.. (2001). The R22X Mutation of the SDHD Gene in Hereditary Paraganglioma Abolishes the Enzymatic Activity of Complex II in the Mitochondrial Respiratory Chain and Activates the Hypoxia Pathway. The American Journal of Human Genetics. 69(6). 1186–1197. 292 indexed citations
20.
Brand, Eva, Norihiro Kato, Nathalie Chatelain, et al.. (1998). Structural analysis and evaluation of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) gene in human essential hypertension. Journal of Hypertension. 16(11). 1627–1633. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Paule Gimenez‐Roqueplo Breakdown of academic impact, for papers by Marcus Quinkler Breakdown of academic impact, for papers by Sergio Fazio Breakdown of academic impact, for papers by Michael J. Koren Breakdown of academic impact, for papers by Emmanuel L. Bravo Breakdown of academic impact, for papers by Odette Poirier Breakdown of academic impact, for papers by Antonio Fernández‐Ortíz Breakdown of academic impact, for papers by Anand Vaidya Breakdown of academic impact, for papers by Tomohiro Sakamoto Breakdown of academic impact, for papers by Gilbert H. Daniels
Rankless by CCL
2026